Canopy Growth Corp — Form 8-K
Filed August 7, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
For Q1 FY2027 (three months ended June 30, 2026), Canopy Growth reported consolidated net revenue of CAD $81.2M, up 13% YoY from CAD $72.1M. Cannabis revenue grew 14% to CAD $65.1M (Canada medical +22% to CAD $25.8M, Canada adult-use +10% to CAD $29.7M, international +10% to CAD $9.6M); Storz Bickel grew 6% to CAD $16.1M. Adjusted gross margin improved to 31% from 25% YoY (consolidating MTL Cannabis acquisition inventory step-up of CAD $2.6M). Adjusted EBITDA loss narrowed 59% to CAD $3.2M loss from CAD $7.9M loss. Net loss was CAD $14.6M vs. CAD $44.9M prior year. Cash position declined from CAD $364.7M to CAD $336.6M; free cash flow outflow was CAD $25.7M.
Why this rating
Modest top-line and margin improvements in a turnaround context. At CAD $81M quarterly revenue (~CAD $324M annualized), typical for a mid-cap cannabis firm. No material transactions, financing, or structural change. MTL integration proceeding as expected.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.